Abstract
Purpose of Review: The aim of this review is to evaluate the emerging role of endoscopic ultrasound (EUS) in the guidance of tumor-targeted therapies for patients with pancreatic cancer (PC). Recent Findings: EUS-guided ablation, brachytherapy, fiducial marker placement, and antitumor agent injection have been described to date. EUS-guided fiducial placement for SBRT in pancreatic cancer has entered the clinical practice and is performed at many centers clinically without a research protocol. EUS-guided brachytherapy and RFA have been shown to be feasible and safe procedures, and potentially offer local disease control. Summary: Other potential techniques of EUS-guided treatment of pancreatic cancer are still considered experimental, with many of them appearing to be safe and reasonably well tolerated. However, their effectiveness and exact role in oncological treatment have yet to be established. Clinical trials with many of the techniques/agents described are underway and multicentric randomized trials with prospective design are eagerly awaited.
| Original language | English (US) |
|---|---|
| Article number | 27 |
| Journal | Current gastroenterology reports |
| Volume | 22 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2020 |
Keywords
- Brachytherapy
- Endoscopic ultrasound
- Fiducial markers
- Pancreatic cancer
- Radiofrequency ablation
ASJC Scopus subject areas
- Gastroenterology